Moderna
MRNA
#1217
Rank
A$24.41 B
Marketcap
$63.44
Share price
-3.95%
Change (1 day)
-57.88%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$24.41 Billion

As of February 2025 Moderna has a market cap of A$24.41 Billion. This makes Moderna the world's 1217th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$24.41 B-1.67%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Feb 1st, 2025 the market cap of Moderna was reported to be:

A$24.41 Billion
by Yahoo Finance info icon info icon
A$24.41 Billion
by CompaniesMarketCap info icon info icon
A$24.41 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.10 B-99.57%๐Ÿ‡บ๐Ÿ‡ธ USA
A$402.29 B 1,547.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.34 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$56.31 B 130.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$336.92 B 1,280.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$4.00 B-83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$589.51 B 2,314.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.79 B-80.37%๐Ÿ‡บ๐Ÿ‡ธ USA